Cargando…
尼洛替尼一线治疗慢性髓性白血病的疗效及影响实现分子学反应的因素分析
OBJECTIVE: This study aimed to investigate the efficacy and safety of nilotinib as the first-line treatment for patients with chronic myelogenous leukemia (CML) and analyze the factors affecting the realization of the major molecular response. METHODS: A retrospective study was conducted on 86 newly...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378290/ https://www.ncbi.nlm.nih.gov/pubmed/32654460 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.06.007 |